Please login (Members) to view content or
(Nonmembers) this article.

No votes yet

Direct-to-Consumer Advertising of Prescription Medications: Implications for Patients With Cancer

Pamela Hallquist Viale
ONF 2002, 29(3), 505-513 DOI: 10.1188/02.ONF.505-513

Purpose/Objectives: To review the phenomenon of direct-to-consumer (DTC) advertising of prescription medications in the media, with an overview of pertinent studies in the literature regarding patients' and healthcare professionals' perspectives on DTC advertising.

Data Sources: Journal articles, media, and clinical experience.

Data Synthesis: DTC advertising of prescription medications is extremely prevalent in U.S. society. Advertising of medications is an expensive business; yearly spending is expected to reach $7.5 billion by 2005. Although opinions vary regarding DTC advertising, healthcare professionals, including oncology nurses, must be prepared to discuss DTC-advertised medications and treatments with their patients.

Conclusions: Communication is the key to helping patients decipher the deluge of DTC advertisements in the media and determine the accuracy of this ever-increasing source of medical information.

Implications for Nursing: Oncology nurses need to be aware of the increases in DTC advertising of prescription medications and the importance of guiding patients through appropriate medication choices by education.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or